Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
biomarkers
immunotherapy
melanoma
outcome prediction
positron emission tomography computed tomography
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
29 07 2021
29 07 2021
Historique:
received:
30
06
2021
revised:
20
07
2021
accepted:
26
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
8
8
2021
Statut:
epublish
Résumé
We aimed to investigate, whether
Identifiants
pubmed: 34359730
pii: cancers13153830
doi: 10.3390/cancers13153830
pmc: PMC8345158
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Iten-Kohaut-Foundation
ID : IA USZF27071
Organisme : Cancer Research Center, Comprehensive Center Zurich, University Hospital Zurich
ID : CRC_13
Commentaires et corrections
Type : ErratumIn
Références
Eur J Cancer. 2020 Feb;126:141-158
pubmed: 31928887
Sci Rep. 2018 Aug 7;8(1):11817
pubmed: 30087375
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2298-2310
pubmed: 31346755
Am J Dermatopathol. 2014 May;36(5):363-79
pubmed: 24803061
Curr Med Chem. 2020;27(17):2792-2813
pubmed: 31804158
Clin Cancer Res. 2020 Aug 15;26(16):4414-4425
pubmed: 32253232
Oncotarget. 2019 May 21;10(36):3373-3384
pubmed: 31164959
Lancet Oncol. 2018 Sep;19(9):1138-1139
pubmed: 30120042
Nuklearmedizin. 2020 Jun;59(3):228-234
pubmed: 32259852
Cancer. 2020 Jan 1;126(1):86-97
pubmed: 31584722
Surg Oncol Clin N Am. 2019 Jul;28(3):403-418
pubmed: 31079796
Eur J Radiol. 2018 Aug;105:1-7
pubmed: 30017264
Curr Oncol Rep. 2018 Sep 24;20(11):87
pubmed: 30250984
J Immunother Cancer. 2017 Nov 21;5(1):95
pubmed: 29162153
Clin Nucl Med. 2016 Jun;41(6):e266-73
pubmed: 27055144
Adv Exp Med Biol. 2014;810:120-40
pubmed: 25207363
Ann Oncol. 2018 Oct 1;29(10):2115-2120
pubmed: 30137228